← All Signals

🏥 FDA: Agebox — Class II

healthcareactionableSource: FDA
88%Confidence
0Views
FDASource
2026-03-16Date

Summary

Agebox recall for an unapproved drug containing ibutamoren highlights regulatory risks in the dietary supplement and wellness space, especially for products making growth-related claims. This may prompt increased FDA scrutiny of similar 'kids growth' supplements.

Actionable: Scrutinize supplement portfolios for undeclared pharmaceutical ingredients and unapproved claims.

AI Confidence: 88%

Data Points

firmAgebox
classificationClass II
statusOngoing
distributionThe product was distributed nationwide in the U.S. Agebox sells its U.S. products through Agebox.com (using Shopify) and Amazon.com. All orders are shipped to customers by Agebox itself; other parties are not involved in the distribution of the physical product.
productAgebox iKids-Growth (Night Formula), 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 850065597027

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now